How severe is CVE-2023-30723?

CVE-2023-30723 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2023-30723 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (28th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-30723?

CVE-2023-30723 affects Samsung Health. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-30723?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2023-30723 published?

CVE-2023-30723 was published on 2023-09-06 and last updated on 2026-06-17.

CVE-2023-30723

CVE-2023-30723 is a medium-severity vulnerability in Samsung Health with a CVSS 3.x base score of 5.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 3.x base score 5.5)
EPSS exploit prediction: 0% (28th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Samsung Health
Published: 2023-09-06
Last modified: 2026-06-17

Description

Improper input validation vulnerability in Samsung Health prior to version 6.24.2.011 allows attackers to write arbitrary file with Samsung Health privilege.

Frequently asked questions

What is CVE-2023-30723?: Improper input validation vulnerability in Samsung Health prior to version 6.24.2.011 allows attackers to write arbitrary file with Samsung Health privilege.
How severe is CVE-2023-30723?: CVE-2023-30723 has a CVSS 3.x base score of 5.5, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-30723 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (28th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-30723?: CVE-2023-30723 affects Samsung Health. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-30723?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-30723 published?: CVE-2023-30723 was published on 2023-09-06 and last updated on 2026-06-17.

References

https://security.samsungmobile.com/serviceWeb.smsb?year=2023&month=09

Affected products (1)

cpe:2.3:a:samsung:health:*:*:*:*:*:*:*:*

More vulnerabilities in Samsung Health

CVE-2021-25401 — High (CVSS 7.8): Intent redirection vulnerability in Samsung Health prior to version 6.16 allows attacker to execute privileged action.
CVE-2025-21059 — Medium (CVSS 6.2): Improper authorization in Samsung Health prior to version 6.30.5.105 allows local attackers to access data in Samsung…
CVE-2025-21019 — Medium (CVSS 5.5): Improper authorization in Samsung Health prior to version 6.30.1.003 allows local attackers to access data in Samsung…
CVE-2021-25425 — Medium (CVSS 5.3): Improper check vulnerability in Samsung Health prior to version 6.17 allows attacker to read internal cache data via…
CVE-2023-42539 — Medium (CVSS 4.7): PendingIntent hijacking vulnerability in ChallengeNotificationManager in Samsung Health prior to version 6.25 allows…
CVE-2024-34597 — Medium (CVSS 4.4): Improper input validation in Samsung Health prior to version 6.27.0.113 allows local attackers to write arbitrary…

All CVEs affecting Samsung Health →